EP 3752509 A1 20201223 - FLAVOCILLIN: A NEW PENICILLIN DERIVATIVE
Title (en)
FLAVOCILLIN: A NEW PENICILLIN DERIVATIVE
Title (de)
FLAVOCILLIN: EIN NEUES PENICILLINDERIVAT
Title (fr)
FLAVOCILLINE : NOUVEL ANTIBIOTIQUE INNOVANT JAMAIS DÉVELOPPÉ PAR LES BACTÉRIES
Publication
Application
Priority
IB 2018050851 W 20180212
Abstract (en)
[origin: WO2019155266A1] This invention is about the discovery of a new novel compound as an antibiotic to stop this potential resistance problem completely. With Organic Chemistry studies and methods and other modified antibiotics, adding a flavonoid group to varibale side R instead which will result in flavocilin formation will be the most effective and revolutionary antibiotic that the bacteria will never be able to resist. Evidentful pathways have been conculded stating that the Flavocilin use in Medicine for heavy infectious conditions or where no other antibiotic works will outweigh all its risks.
IPC 8 full level
C07D 499/74 (2006.01); A61K 31/43 (2006.01); A61K 31/431 (2006.01); A61P 31/04 (2006.01)
CPC (source: EP)
C07D 499/74 (2013.01)
Citation (search report)
See references of WO 2019155266A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2019155266 A1 20190815; WO 2019155266 A8 20200618; EP 3752509 A1 20201223
DOCDB simple family (application)
IB 2018050851 W 20180212; EP 18713342 A 20180212